publication venue for
- Corrigendum to "DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients" [Radiother Oncol (2021) 164:146-154]. 2022
- An update to the American Radium Society's appropriate use criteria of lower grade Gliomas: Integration of IDH inhibitors. 2024
- Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.. 202. 2024
- A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors. 2024
- Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics.. 199. 2024
- Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis. 2024
- "Primer shot" fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer.. 190. 2023
- Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation.. 190. 2023
- Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation.. 190. 2023
- Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.. 185. 2023
- Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients.. 168. 2022
- Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab.. 167. 2021
- DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients.. 164. 2021
- Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy.. 159. 2021
- Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures.. 153. 2020
- The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.. 153. 2020
- Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab.. 149. 2020
- Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.. 144. 2019
- Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression?. 143. 2019
- Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.. 138. 2019
- Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.. 135. 2019
- Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.. 128. 2018
- A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma.. 127. 2018
- Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study.. 129. 2018
- Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy.. 127. 2018
- Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features.. 127. 2017
- Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation.. 125. 2017
- Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5×6Gy) conformal radiotherapy.. 123. 2017
- Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.. 122. 2016
- Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis.. 120. 2016
- Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy.. 119. 2016
- Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer.. 118. 2016
- Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma.. 118. 2015
- Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma.. 114. 2014
- Ewing sarcoma in adults treated with modern radiotherapy techniques.. 113. 2014
- Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.. 113. 2014
- A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.. 111. 2014
- Axitinib sensitization of high Single Dose Radiotherapy.. 111. 2014
- Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data.. 110. 2014
- Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions.. 109. 2013
- STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics.. 110. 2013
- Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis.. 107. 2013
- Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo.. 105. 2012
- Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review.. 101. 2011
- Acquisition of MV-scatter-free kilovoltage CBCT images during RapidArc™ or VMAT.. 100. 2011
- Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients.. 97. 2010
- Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction.. 94. 2010
- Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells.. 92. 2009
- Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry.. 88. 2008
- Exclusive radiotherapy for primary squamous cell carcinoma of the vagina.. 85. 2007
- Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: the appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results.. 77. 2005
- Comparison of end normal inspiration and expiration for gated intensity modulated radiation therapy (IMRT) of lung cancer.. 75. 2005
- Dosimetric effect of respiratory motion in external beam radiotherapy of the lung.. 71. 2004
- Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer.. 63. 2002
- Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapy.. 62. 2002
- Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).. 62. 2002
- Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.. 55. 2000
- Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue.. 53. 1999
- Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.. 50. 1999
- Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study.. 46. 1998
- Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.. 44. 1997
- Optimization of intensity-modulated 3D conformal treatment plans based on biological indices.. 37. 1995
- Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer.. 35. 1995
- An equation for the dose response of radiation-induced apoptosis: possible incorporation with the LQ model.. 33. 1994
- The potential and limitations of the inverse radiotherapy technique.. 32. 1994
- High dose-high precision in radiation oncology.. 29. 1993
- Perspectives of multidimensional conformal radiation treatment.. 29. 1993
- Chordoma: results of radiation therapy in eighteen patients.. 29. 1993
- Tumor control probability for permanent implants in prostate.. 28. 1993
- Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation.. 26. 1993
- High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model.. 25. 1992
- Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines.. 23. 1992
- Total body irradiation for bone marrow transplantation: the Memorial Sloan-Kettering Cancer Center experience.. 18 Suppl 1. 1990
- Combined modality treatment for stage III ovarian carcinoma.. 3. 1985
- Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis.. 3. 1985
- To the Editors.. 147. 2020
- On autoradiographic studies comparing the distributions of ¹⁸F- and ¹⁴C-labeled compounds in tumor tissue specimens. 2010
- Challenges and opportunities in primary CNS lymphoma: A systematic review. 2017
- Dose-rate effects in external beam radiotherapy redux. 2010
- Executive summary of American Radium Society's appropriate use criteria for the postoperative management of lower grade gliomas. 2022
- Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control. 2014
- Is there a role for endorectal balloons in prostate radiotherapy? A systematic review. 2010